Management of Cancer-Associated Venous Thromboembolism in the Emergency Department

Patients with cancer are at increased risk of venous thromboembolism, and emergency physicians can play a significant role in addressing one of the leading causes of morbidity and mortality in this patient population. However, there are no comprehensive guidelines addressing the approach to cancer-a...

Full description

Saved in:
Bibliographic Details
Published in:Annals of emergency medicine 2017-06, Vol.69 (6), p.768-776
Main Authors: Nene, Rahul V., PhD, Coyne, Christopher J., MD, MPH
Format: Article
Language:English
Subjects:
Anticoagulants - therapeutic use
Contraindications
Emergency
Emergency Service, Hospital
Guidelines as Topic
Heparin, Low-Molecular-Weight - therapeutic use
Humans
Neoplasms - complications
Practice Guidelines as Topic
Recurrence
Risk Factors
Secondary Prevention - methods
Venous Thromboembolism - drug therapy
Venous Thromboembolism - prevention & control
Vitamin K - antagonists & inhibitors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c432t-a11b8a6a3c0cc5d67f18d9e60326fc7ab8d1bc2d3d164b0a91e01399dc7c6e03
cites cdi_FETCH-LOGICAL-c432t-a11b8a6a3c0cc5d67f18d9e60326fc7ab8d1bc2d3d164b0a91e01399dc7c6e03
container_end_page 776
container_issue 6
container_start_page 768
container_title Annals of emergency medicine
container_volume 69
creator Nene, Rahul V., PhD
Coyne, Christopher J., MD, MPH
description Patients with cancer are at increased risk of venous thromboembolism, and emergency physicians can play a significant role in addressing one of the leading causes of morbidity and mortality in this patient population. However, there are no comprehensive guidelines addressing the approach to cancer-associated venous thromboembolism in the emergency department. Here, we review the guidelines put forth by various national and international cancer societies and highlight how emergency physicians can help institute appropriate treatment and prevent the recurrence of venous thromboembolism in cancer patients. We also address areas of controversy and highlight topics that require further research.
doi_str_mv 10.1016/j.annemergmed.2016.12.003
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1865820021</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0196064416315190</els_id><sourcerecordid>1865820021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c432t-a11b8a6a3c0cc5d67f18d9e60326fc7ab8d1bc2d3d164b0a91e01399dc7c6e03</originalsourceid><addsrcrecordid>eNqNkU9r3DAQxUVpabZpv0Jxb73YnZG8snUphE36BxIC6dKrkKVxoq0tbyVvYb99ZTaB0lMOQqB5783oN4x9QKgQUH7aVSYEGinej-Qqnp8q5BWAeMFWCKopZSPhJVsBKlmCrOsz9ialHQComuNrdsZblArWYsXubkww9zkrzMXUFxsTLMXyIqXJejOTK35SmA6p2D7EaewmymfwaSx8KOYHKq6WISjYY3FJexPnJecte9WbIdG7x_ucbb9cbTffyuvbr983F9elrQWfS4PYtUYaYcHatZNNj61TJEFw2dvGdK3DznInHMq6A6OQAIVSzjZWEohz9vEUu4_T7wOlWY8-WRoGEyhPrLGV65YDcMxSdZLaOKUUqdf76EcTjxpBL0T1Tv9DVC9ENXKdiWbv-8c2h26pPTmfEGbB5iSg_Nc_nqJO1mck5HwkO2s3-We1-fxfih188NYMv-hIaTcdYsgwNeqUDfrHstplsygFrlGB-AvREqL1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1865820021</pqid></control><display><type>article</type><title>Management of Cancer-Associated Venous Thromboembolism in the Emergency Department</title><source>ScienceDirect Freedom Collection</source><creator>Nene, Rahul V., PhD ; Coyne, Christopher J., MD, MPH</creator><creatorcontrib>Nene, Rahul V., PhD ; Coyne, Christopher J., MD, MPH</creatorcontrib><description>Patients with cancer are at increased risk of venous thromboembolism, and emergency physicians can play a significant role in addressing one of the leading causes of morbidity and mortality in this patient population. However, there are no comprehensive guidelines addressing the approach to cancer-associated venous thromboembolism in the emergency department. Here, we review the guidelines put forth by various national and international cancer societies and highlight how emergency physicians can help institute appropriate treatment and prevent the recurrence of venous thromboembolism in cancer patients. We also address areas of controversy and highlight topics that require further research.</description><identifier>ISSN: 0196-0644</identifier><identifier>EISSN: 1097-6760</identifier><identifier>DOI: 10.1016/j.annemergmed.2016.12.003</identifier><identifier>PMID: 28169053</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Anticoagulants - therapeutic use ; Contraindications ; Emergency ; Emergency Service, Hospital ; Guidelines as Topic ; Heparin, Low-Molecular-Weight - therapeutic use ; Humans ; Neoplasms - complications ; Practice Guidelines as Topic ; Recurrence ; Risk Factors ; Secondary Prevention - methods ; Venous Thromboembolism - drug therapy ; Venous Thromboembolism - prevention &amp; control ; Vitamin K - antagonists &amp; inhibitors</subject><ispartof>Annals of emergency medicine, 2017-06, Vol.69 (6), p.768-776</ispartof><rights>American College of Emergency Physicians</rights><rights>2016 American College of Emergency Physicians</rights><rights>Copyright © 2016 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c432t-a11b8a6a3c0cc5d67f18d9e60326fc7ab8d1bc2d3d164b0a91e01399dc7c6e03</citedby><cites>FETCH-LOGICAL-c432t-a11b8a6a3c0cc5d67f18d9e60326fc7ab8d1bc2d3d164b0a91e01399dc7c6e03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27898,27899</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28169053$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nene, Rahul V., PhD</creatorcontrib><creatorcontrib>Coyne, Christopher J., MD, MPH</creatorcontrib><title>Management of Cancer-Associated Venous Thromboembolism in the Emergency Department</title><title>Annals of emergency medicine</title><addtitle>Ann Emerg Med</addtitle><description>Patients with cancer are at increased risk of venous thromboembolism, and emergency physicians can play a significant role in addressing one of the leading causes of morbidity and mortality in this patient population. However, there are no comprehensive guidelines addressing the approach to cancer-associated venous thromboembolism in the emergency department. Here, we review the guidelines put forth by various national and international cancer societies and highlight how emergency physicians can help institute appropriate treatment and prevent the recurrence of venous thromboembolism in cancer patients. We also address areas of controversy and highlight topics that require further research.</description><subject>Anticoagulants - therapeutic use</subject><subject>Contraindications</subject><subject>Emergency</subject><subject>Emergency Service, Hospital</subject><subject>Guidelines as Topic</subject><subject>Heparin, Low-Molecular-Weight - therapeutic use</subject><subject>Humans</subject><subject>Neoplasms - complications</subject><subject>Practice Guidelines as Topic</subject><subject>Recurrence</subject><subject>Risk Factors</subject><subject>Secondary Prevention - methods</subject><subject>Venous Thromboembolism - drug therapy</subject><subject>Venous Thromboembolism - prevention &amp; control</subject><subject>Vitamin K - antagonists &amp; inhibitors</subject><issn>0196-0644</issn><issn>1097-6760</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqNkU9r3DAQxUVpabZpv0Jxb73YnZG8snUphE36BxIC6dKrkKVxoq0tbyVvYb99ZTaB0lMOQqB5783oN4x9QKgQUH7aVSYEGinej-Qqnp8q5BWAeMFWCKopZSPhJVsBKlmCrOsz9ialHQComuNrdsZblArWYsXubkww9zkrzMXUFxsTLMXyIqXJejOTK35SmA6p2D7EaewmymfwaSx8KOYHKq6WISjYY3FJexPnJecte9WbIdG7x_ucbb9cbTffyuvbr983F9elrQWfS4PYtUYaYcHatZNNj61TJEFw2dvGdK3DznInHMq6A6OQAIVSzjZWEohz9vEUu4_T7wOlWY8-WRoGEyhPrLGV65YDcMxSdZLaOKUUqdf76EcTjxpBL0T1Tv9DVC9ENXKdiWbv-8c2h26pPTmfEGbB5iSg_Nc_nqJO1mck5HwkO2s3-We1-fxfih188NYMv-hIaTcdYsgwNeqUDfrHstplsygFrlGB-AvREqL1</recordid><startdate>20170601</startdate><enddate>20170601</enddate><creator>Nene, Rahul V., PhD</creator><creator>Coyne, Christopher J., MD, MPH</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170601</creationdate><title>Management of Cancer-Associated Venous Thromboembolism in the Emergency Department</title><author>Nene, Rahul V., PhD ; Coyne, Christopher J., MD, MPH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c432t-a11b8a6a3c0cc5d67f18d9e60326fc7ab8d1bc2d3d164b0a91e01399dc7c6e03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Anticoagulants - therapeutic use</topic><topic>Contraindications</topic><topic>Emergency</topic><topic>Emergency Service, Hospital</topic><topic>Guidelines as Topic</topic><topic>Heparin, Low-Molecular-Weight - therapeutic use</topic><topic>Humans</topic><topic>Neoplasms - complications</topic><topic>Practice Guidelines as Topic</topic><topic>Recurrence</topic><topic>Risk Factors</topic><topic>Secondary Prevention - methods</topic><topic>Venous Thromboembolism - drug therapy</topic><topic>Venous Thromboembolism - prevention &amp; control</topic><topic>Vitamin K - antagonists &amp; inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nene, Rahul V., PhD</creatorcontrib><creatorcontrib>Coyne, Christopher J., MD, MPH</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of emergency medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nene, Rahul V., PhD</au><au>Coyne, Christopher J., MD, MPH</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of Cancer-Associated Venous Thromboembolism in the Emergency Department</atitle><jtitle>Annals of emergency medicine</jtitle><addtitle>Ann Emerg Med</addtitle><date>2017-06-01</date><risdate>2017</risdate><volume>69</volume><issue>6</issue><spage>768</spage><epage>776</epage><pages>768-776</pages><issn>0196-0644</issn><eissn>1097-6760</eissn><abstract>Patients with cancer are at increased risk of venous thromboembolism, and emergency physicians can play a significant role in addressing one of the leading causes of morbidity and mortality in this patient population. However, there are no comprehensive guidelines addressing the approach to cancer-associated venous thromboembolism in the emergency department. Here, we review the guidelines put forth by various national and international cancer societies and highlight how emergency physicians can help institute appropriate treatment and prevent the recurrence of venous thromboembolism in cancer patients. We also address areas of controversy and highlight topics that require further research.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28169053</pmid><doi>10.1016/j.annemergmed.2016.12.003</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0196-0644
ispartof Annals of emergency medicine, 2017-06, Vol.69 (6), p.768-776
issn 0196-0644
1097-6760
language eng
recordid cdi_proquest_miscellaneous_1865820021
source ScienceDirect Freedom Collection
subjects Anticoagulants - therapeutic use
Contraindications
Emergency
Emergency Service, Hospital
Guidelines as Topic
Heparin, Low-Molecular-Weight - therapeutic use
Humans
Neoplasms - complications
Practice Guidelines as Topic
Recurrence
Risk Factors
Secondary Prevention - methods
Venous Thromboembolism - drug therapy
Venous Thromboembolism - prevention & control
Vitamin K - antagonists & inhibitors
title Management of Cancer-Associated Venous Thromboembolism in the Emergency Department
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-27T09%3A53%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20Cancer-Associated%20Venous%20Thromboembolism%20in%20the%20Emergency%20Department&rft.jtitle=Annals%20of%20emergency%20medicine&rft.au=Nene,%20Rahul%20V.,%20PhD&rft.date=2017-06-01&rft.volume=69&rft.issue=6&rft.spage=768&rft.epage=776&rft.pages=768-776&rft.issn=0196-0644&rft.eissn=1097-6760&rft_id=info:doi/10.1016/j.annemergmed.2016.12.003&rft_dat=%3Cproquest_cross%3E1865820021%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c432t-a11b8a6a3c0cc5d67f18d9e60326fc7ab8d1bc2d3d164b0a91e01399dc7c6e03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1865820021&rft_id=info:pmid/28169053&rfr_iscdi=true